MA ANA ARBO: Open Payments
NPI 1912349291 · MERCED, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,870 in 39 payments from 11 companies in 2025. Trend: 2023 $516 · 2024 $833 · 2025 $1,870
Food & beverage: $1,133Travel & lodging: $737
| Company | Payments | Amount |
|---|---|---|
| MIMEDX Group, Inc. | 9 | $1,081 |
| AstraZeneca Pharmaceuticals LP | 9 | $217 |
| Novo Nordisk Inc | 5 | $159 |
| GlaxoSmithKline, LLC. | 3 | $108 |
| Amgen Inc. | 3 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Lilly USA, LLC | 2 | $43 |
| ABIOMED | 1 | $42 |
| Corcept Therapeutics | 2 | $37 |
| Globus Medical, Inc. | 1 | $32 |
Products named: AIRSUPRA, Ozempic, AREXVY, OTEZLA, Kerendia, MOUNJARO, Korlym, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
